Malaysia Inflation Remains Stable At 4.0%

Malaysia's consumer price inflation held steady in November after easing to a 4-month low in October, data from the Department of Statistics showed on Friday.

The consumer price index climbed 4.0 percent year-on-year in November, the same rate of increase as in October. Prices have been rising since February last year.

Earlier, the central bank of Malaysia said headline and core inflation were expected to remain elevated in 2023 amid both demand and cost pressures, as well as any changes to domestic policy measures.

Prices for food and non-alcoholic beverages grew the most by 7.3 percent annually in November, and transport charges were 5.0 percent higher.

Charges for restaurants and hotels were 7.0 percent more expensive compared to last year, while utility costs rose only 1.4 percent.

Data also showed that core inflation stood at 4.2 percent in November versus 4.1 percent in the prior month.

On a monthly basis, consumer prices increased 0.3 percent in November versus a 0.2 percent rise in October.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT